You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Metabolic conditions

Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate

  • Evidence summary
  • Reference number: ESUOM4
  • Published:  29 January 2013
  • Advice
  • Information for the public
Download (PDF)
  • Key points from the evidence
  • Overview for healthcare professionals
  • Relevance to NICE guidance programmes
  • Intervention and alternatives
  • Evidence review: efficacy
  • Evidence: safety
  • Evidence: economic issues
  • Evidence strengths and limitations
  • Summary for patients
  • References
  • Changes after publication
  • Development of this evidence summary
  • Appendix: Search strategy and evidence selection
  • About 'Evidence summaries: unlicensed or off-label medicines'

Relevance to NICE guidance programmes

No NICE guidance on preventing or treating recurrence of hypomagnesaemia was identified.


Next page Intervention and alternatives Previous page Overview for healthcare professionals
Back to top